Mirae Asset Global ETFs Holdings
ZNTL icon

Mirae Asset Global ETFs Holdings’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34,202
Closed -$54.4K – 3272
2025
Q1 		$54.4K Buy
34,202
+1,488
+5% +$3.21K ﹤0.01% 2833
2024
Q4 		$99.1K Buy
32,714
+1,452
+5% +$4.76K ﹤0.01% 2701
2024
Q3 		$115K Sell
31,262
-4,333
-12% -$15.7K ﹤0.01% 2652
2024
Q2 		$146K Buy
+35,595
New +$398K ﹤0.01% 2410

Other funds holding ZNTL

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ZNTL Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Zentalis Pharmaceuticals (ZNTL) in Q2 2025, closing a stake of 34,202 shares — an estimated $54.4K sold.

Mirae Asset Global ETFs Holdings first reported a position in ZNTL in Q2 2024 and held it in 4 quarters. The position peaked at $146K in Q2 2024. 117 funds tracked by Wall St. Rank hold ZNTL as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Zentalis Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 34,202 Zentalis Pharmaceuticals shares in Q2 2025, an estimated $54.4K.
  • Mirae Asset Global ETFs Holdings first reported a position in Zentalis Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Zentalis Pharmaceuticals position peaked at $146K in Q2 2024.
  • 117 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.